New Bioresorbable Vascular Scaffold from Meril, an Indian Multinational Meril, a large Indianآ*medical device firm, has developed a drug-eluting Bioresorbable Vascular scaffold, which looks like a stent but that eventually and slowly degrades is washed away by the body. The MeRes100 is made of PLLA coated with PDLLA, both biodegradable polymers, while Sirolimus (rapamycin), the immu**suppressant common in drug eluting stents, isآ*embedded within the coating. The struts of the device are onlyآ*100 خ¼m thick while providing the strength needed to maintain an open lumen.
It comes with its own delivery mechanism based on a balloon catheter and the implant has three radiopaque markers on its tips to make placement easier under fluoroscopy and large size matrix.
Here’s a summary from an ongoingآ*trial in India involving 108 patients at 16 different hospitals, according to Meril:
MeRes-1 study was recently presented by Dr. Ashok Seth (New Delhi, India) during TCT 2016 involving 108 subjects treated across 16 prominent clinical sites in India. There were ** instances of MACE or Scaffold thrombosis within 6 months. On QCA analysis, in-scaffold late lumen loss was 0.15آ±0.23 mm & OCT analysis showed 99.3% of struts covered at 6 months. The 6-months clinical and angiographic/OCT/IVUS results demonstrated excellent safety & efficacy of this promising next generation BRS.
02-24-2017, 07:23 PM
New Bioresorbable Vascular Scaffold from Meril, an Indian Multinational
Meril, a large Indianآ*medical device firm, has developed a drug-eluting Bioresorbable Vascular scaffold, which looks like a stent but that eventually and slowly degrades is washed away by the body. The MeRes100 is made of PLLA coated with PDLLA, both biodegradable polymers, while Sirolimus (rapamycin), the immu**suppressant common in drug eluting stents, isآ*embedded within the coating. The struts of the device are onlyآ*100 خ¼m thick while providing the strength needed to maintain an open lumen.
العرض الشجري